| Literature DB >> 27860276 |
Lana Gaelings1, Sandra Söderholm2,3, Andrii Bugai4, Yu Fu1, Jatin Nandania1, Bert Schepens5,6, Martina B Lorey3, Janne Tynell7, Liesbeth Vande Ginste4,5, Ronan Le Goffic8, Matthew S Miller9, Marika Kuisma4, Varpu Marjomäki10, Jef De Brabander11, Sampsa Matikainen3, Tuula A Nyman12, Dennis H Bamford2, Xavier Saelens4,5, Ilkka Julkunen7,13, Henrik Paavilainen13, Veijo Hukkanen13, Vidya Velagapudi1, Denis E Kainov1.
Abstract
Influenza A viruses (IAVs) remain serious threats to public health because of the shortage of effective means of control. Developing more effective virus control modalities requires better understanding of virus-host interactions. It has previously been shown that IAV induces the production of kynurenine, which suppresses T-cell responses, enhances pain hypersensitivity and disturbs behaviour in infected animals. However, the regulation of kynurenine biosynthesis during IAV infection remains elusive. Here we showed that IAV infection induced expression of interferons (IFNs), which upregulated production of indoleamine-2,3-dioxygenase (IDO1), which catalysed the kynurenine biosynthesis. Furthermore, IAV attenuated the IDO1 expression and the production of kynurenine through its NS1 protein. Interestingly, inhibition of viral replication prior to IFN induction limited IDO1 expression, while inhibition after did not. Finally, we showed that kynurenine biosynthesis was activated in macrophages in response to other stimuli, such as influenza B virus, herpes simplex virus 1 and 2 as well as bacterial lipopolysaccharides. Thus, the tight regulation of the kynurenine biosynthesis by host cell and, perhaps, pathogen might be a basic signature of a wide range of host-pathogen interactions, which should be taken into account during development of novel antiviral and antibacterial drugs.Entities:
Keywords: host-pathogen interaction; indoleamine-pyrrole 2,3-dioxygenase (IDO1); influenza virus; innate immunity; interferon
Mesh:
Substances:
Year: 2016 PMID: 27860276 DOI: 10.1111/febs.13966
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542